On the backdrop of the spread of coronavirus infection in Russia suppliers began to raise prices for drugs, in some cases, the price increase reaches 15%, writes “Kommersant”.
According to General Director DSM Group Sergey Shulyak, the number of vendors increased prices on remaining inventory, as a new party they will have to acquire taking into account the fall of the ruble.
The CEO of the supplier of drugs, CV PROTEK Dmitry Pogrebinsky says that as Disposals from warehouses parties with lower prices will inevitably increase the cost of implementation. He argues that rising prices for drugs that are not included in the EDL does not exceed 5%. Moreover, the top Manager connects the events with the fact that in the end of 2019, “due to various reasons” increased prices of the producers, and in February the cost of drugs rose because of devaluation of the ruble. This also applies to the drugs produced in Russia, he said.
The current increase in prices allowed the suppliers to cut off part of the customers, as due to excessive demand they could not handle the huge amount of orders. The demand for drugs in the pharmaceutical retail started to rise sharply since the middle of last month. But from 30 March to 5 April, the sales of medicines in drugstores in real terms began to decline: the average demand fell by 20% year-on-year. The drop in sales at DSM Group explained the isolation imposed by the regime and reserves in the period of excitement. According to analysts, the purchased drugs to consumers may be sufficient for up to six months. In addition, the regime of self-isolation can still be extended, which threatens to further the decline of sales in pharmacies.